Oncotarget

Research Papers:

Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling

Xuan Sun, Suoning Liu, Daguang Wang, Yang Zhang, Wei Li, Yuchen Guo, Hua Zhang and Jian Suo _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:15168-15181. https://doi.org/10.18632/oncotarget.14834

Metrics: PDF 2201 views  |   HTML 3797 views  |   ?  


Abstract

Xuan Sun1, Suoning Liu1, Daguang Wang1, Yang Zhang1, Wei Li1, Yuchen Guo1, Hua Zhang1, Jian Suo1

1Department of Gastrointestinal Surgery, First Hospital of Jilin University, Changchun, Jilin province, China

Correspondence to:

Jian Suo, email: [email protected]

Keywords: canonical wnt signaling, negatively regulate, CD4+ T cells immunity, colorectal cancer

Received: September 16, 2016     Accepted: January 13, 2017     Published: January 27, 2017

ABSTRACT

Understanding how colorectal cancer escapes from immunosurveillance and immune attack is important for developing novel immunotherapies for colorectal cancer. In this study we evaluated the role of canonical Wnt signaling in the regulation of T cell function in a mouse colorectal cancer model. We found that colorectal cancer cells expressed abundant Wnt ligands, and intratumoral T cells expressed various Frizzled proteins. Meanwhile, both active β-catenin and total β-catenin were elevated in intratumoral T cells. In vitro study indicated that colorectal cancer cells suppressed IFN-γ expression and increased IL-17a expression in activated CD4+ T cells. However, the cytotoxic activity of CD8+ T cells was not altered by colorectal cancer cells. To further evaluate the importance of Wnt signaling for CD4+ T cell-mediated cancer immunity, β-catenin expression was enforced in CD4+ T cells using lentiviral transduction. In an adoptive transfer model, enforced expression of β-catenin in intratumoral CD4+ T cells increased IL-17a expression, enhanced proliferation and inhibited apoptosis of colorectal cancer cells. Taken together, our study disclosed a new mechanism by which colorectal cancer impairs T cell immunity.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14834